Article
Inhibition of the mutant p53 gene in transformation assays.
The Journal of surgical research - 1 Apr 1992
Beenken S W, Raycroft L, Lozano G
Abstract excerpt
Mutation of the p53 gene is a key element in the development of several human cancers. Intron 4, a noncoding region of the p53 gene, is required for optimal expression of that gene. We have previously shown that nuclear protein binds intron 4 and have defined the protein-binding site. In this paper we address the question, "Does the mutant p53 gene's ability to transform cells to the malignant phenotype depend on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
